Marta Łuksza

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

22h-index6.6kcitations61works21.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(16), SARS-CoV-2 and COVID-19 Research(11), vaccines and immunoinformatics approaches(10), COVID-19 epidemiological studies(8), Cancer Genomics and Diagnostics(8)

Publications61 total

Nomenclature for tracking of genetic variation of seasonal influenza viruses
2025Open Access
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
iScience·2025· 1 citedOpen Access
Concepts and Methods for Predicting Viral Evolution
Methods in molecular biology·2025· 10 cited
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.
2024· 2 citedOpen Access
Abstract 4093: Modeling tumor immunoediting under immune selective pressure to inform neoantigen landscape dynamics for effective cancer vaccines
Cancer Research·2024
Concepts and methods for predicting viral evolution
2024· 9 citedOpen Access
Concepts and methods for predicting viral evolution
arXiv (Cornell University)·2024· 1 citedOpen Access
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
Cancer Cell·2024· 148 citedOpen Access
Population immunity predicts evolutionary trajectories of SARS-CoV-2
Cell·2023· 83 citedOpen Access
Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data
mBio·2023· 18 citedOpen Access
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature·2023· 1.1k citedOpen Access
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Nature Genetics·2023· 162 citedOpen Access
Abstract 610: Modeling tumor immunoediting coupled with T-cell repertoire dynamic
Cancer Research·2023
Abstract 3468: Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer
Cancer Research·2023
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site
Nature Communications·2022· 23 citedOpen Access
Abstract IA11: Immune selection and predictability of cancer evolution
Cancer Immunology Research·2022
Vaccination shapes evolutionary trajectories of SARS-CoV-2
2022· 6 citedOpen Access
Vaccination shapes evolutionary trajectories of SARS-CoV-2
arXiv (Cornell University)·2022· 1 citedOpen Access
Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness
Nature·2022· 2 citedOpen Access
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
Nature·2022· 180 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Benjamin D. Greenbaum(26), Michael Lässig(14), David Hoyos(13), Denis Ruchnewitz(12), Vinod P. Balachandran(11), Jedd D. Wolchok(11), Taha Merghoub(11), Matthew D. Hellmann(11), Jayon Lihm(8), Hira Rizvi(8), Zachary Sethna(7), Viviana Simon(7), Harm van Bakel(7), Matthijs Meijers(7), Christine A. Iacobuzio–Donahue(6), Hala Alshammary(6), Arnold J. Levine(5), Miriam Mérad(5), Luis A. Rojas(5), Kevin C. Soares(5)